MI-CARE Team Model for Hypertension

(MI-CARE Trial)

Overseen By Susan J Shaw, PhD

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of Arizona

Must be taking: Hypertension medications

Disqualifiers: Inability to consent, Hostility

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

Duration: 6 months

230 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new method to help people with high blood pressure adhere to their medication plans. It employs a team approach, where pharmacists and community health workers collaborate to support patients. The trial specifically targets African-American or Latino individuals who already take medication for high blood pressure but struggle with adherence. Participants should be using at least five different chronic medications and have less than 85% adherence to their hypertension medication. The goal is to determine if this team approach, called My Interprofessional Care team for Adherence and Research Engagement (MI-CARE), can improve medication adherence and better control blood pressure for those at high risk. As an unphased trial, this study provides a unique opportunity to contribute to innovative strategies for managing high blood pressure.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems likely that you will continue your current medications since the trial focuses on improving medication adherence for hypertension.

What prior data suggests that the MI-CARE intervention is safe for patients with hypertension?

Research has shown that team-based care, such as the MI-CARE program, is safe and well-received. This approach involves various healthcare professionals collaborating to manage conditions like high blood pressure. Studies have found that this method enhances patient safety and quality of care. People collaborating with multiple health professionals often report positive experiences and better health outcomes.

For example, teamwork in healthcare has been linked to better control of chronic diseases, leading to improved management of conditions without added risks. No major negative side effects have been reported with this type of care. Overall, the team-based care model used in MI-CARE is considered safe for patients. ^{1 2 3 4 5}

Why are researchers excited about this trial?

Researchers are excited about the MI-CARE intervention for hypertension because it offers a personalized, team-based approach that integrates pharmacists and community health workers to optimize patient care. Unlike traditional treatments that primarily focus on medication prescriptions, MI-CARE emphasizes medication optimization through close monitoring and feedback on blood pressure control and adherence. This approach aims to provide more tailored and coordinated care, potentially leading to better health outcomes for high-risk patients.

What evidence suggests that the MI-CARE intervention is effective for hypertension?

Research has shown that team-based care can greatly improve blood pressure control. In this trial, participants in the MI-CARE Intervention arm will receive coordinated care from a pharmacist-community health worker team, which studies have demonstrated better manages high blood pressure. For example, patients receiving this type of care often see their blood pressure improve over time. This approach also helps patients take their medications correctly and consistently by combining the skills of different healthcare providers to better handle long-term health issues. Overall, evidence supports that team-based care effectively manages high blood pressure. ^{1 3 4 5 6}

Who Is on the Research Team?

Jeannie K Lee, PharmD

Principal Investigator

University of Arizona College of Pharmacy

Are You a Good Fit for This Trial?

This trial is for adults over 18 who identify as African-American, Latino, or Vietnamese and speak English, Spanish, or Vietnamese. They must have high blood pressure treated with medication, use 5 or more chronic medications and have less than 80% adherence to their hypertension medication.

Inclusion Criteria

I am taking medication for high blood pressure.

I often forget to take my blood pressure medication.

I take 5 or more medications regularly for chronic conditions.

Exclusion Criteria

I understand the details and implications of the clinical trial.

I am willing and able to follow the study's requirements.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the MI-CARE intervention, which includes medication optimization and tailored case management by a pharmacist-CHW team. Pill counts and blood pressure measurements are conducted at each visit.

6 months

Regular visits with the pharmacist-CHW team

Booster

A booster session is conducted one month after the intervention visits to reinforce adherence and blood pressure control.

1 month

Follow-up

Participants are monitored for medication adherence, blood pressure, and other health outcomes post-intervention.

6 months

What Are the Treatments Tested in This Trial?

Interventions

• My Interprofessional Care team for Adherence and Research Engagement (MI-CARE)

Trial Overview

The MI-CARE program is being tested; it's a coordinated care team approach designed to improve how well patients stick to their blood pressure medication regimen by providing comprehensive primary care through an interprofessional team.

How Is the Trial Designed?

Group I: MI-CARE Intervention Experimental Treatment 1 Intervention

Pharmacist-community health worker team providing coordinated care tailored to high-risk patients with hypertension. MI-CARE intervention participants will meet with the pharmacist-CHW team for medication optimization and tailored case management. Pill counts will be completed to assess adherence and BP will be measured at each visit to guide antihypertensive medication optimization and provide feedback to participants about their adherence and BP control. Intervention visits will be followed by a booster one month later.

Group II: Waitlist Control Active Control 1 Intervention

Participants enrolled in this arm will receive usual medical care

Who Is Running the Clinical Trial?

University of Arizona

Lead Sponsor

Trials

545

Recruited

161,000+

University of Massachusetts, Amherst

Collaborator

Trials

83

Recruited

3,474,000+

Published Research Related to This Trial

This study evaluates a collaborative care model involving physicians and pharmacists to improve blood pressure control across 27 diverse primary care offices, focusing on underrepresented minorities and varying levels of clinical pharmacy services.

The randomized trial will assess the effectiveness and sustainability of this model over 9 or 24 months, providing insights into its potential for widespread adoption in diverse populations.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

A cluster-randomized effectiveness trial of a physician-pharmacist collaborative model to improve blood pressure control. Carter, BL., Clarke, W., Ardery, G., et al.[2021]

All 23 countries and regions surveyed reported integrating team-based care for basic hypertension management, but only 30% implemented it for more advanced tasks, highlighting a gap in comprehensive care.

Healthcare workers recognized the benefits of team-based hypertension care, but faced barriers such as inadequate training (83%) and regulatory issues (76%), suggesting that improving training and support systems is crucial for effective implementation.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Landscape of team-based care to manage hypertension: results from two surveys in low/middle-income countries. Ogungbe, O., Cazabon, D., Moran, AE., et al.[2023]

A multidisciplinary approach involving nurses, pharmacists, and physicians significantly improved blood pressure control in an underserved urban practice, with rates increasing from 51.0% to 67.4% during the intervention phase.

While medication adherence improved during the intervention, it did not remain elevated after the study ended, highlighting the need for ongoing support to maintain adherence in managing hypertension.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Effectiveness of a multidisciplinary intervention to improve hypertension control in an urban underserved practice. Fortuna, RJ., Nagel, AK., Rose, E., et al.[2022]

The Hypertension Management Initiative (HMI) significantly improved patient engagement and knowledge about hypertension management, with 199 out of 3934 enrolled patients reporting satisfaction with regular monitoring and goal-setting for their health.

Healthcare providers noted that the HMI enhanced their confidence in diagnosing and managing hypertension, improved interprofessional collaboration, and allowed nurses to take on more independent roles, ultimately reducing the workload for physicians.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Hypertension management initiative: qualitative results from implementing clinical practice guidelines in primary care through a facilitated practice program. Tobe, SW., Moy Lum-Kwong, M., Von Sychowski, S., et al.[2013]

A 22-month observational study showed that integrating pharmacists into care for patients with hypertension and diabetes improved patient engagement, as those in the pharmacy group had more frequent visits with their primary care providers.

Despite increased engagement, there were no significant differences in achieving treatment goals for blood pressure and A1c levels between patients receiving collaborative care and those receiving standard care, indicating that managing diabetes may be more challenging than hypertension.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Clinical Pharmacist Team-Based Care in a Safety Net Medical Home: Facilitators and Barriers to Chronic Care Management. Price-Haywood, EG., Amering, S., Luo, Q., et al.[2023]

Nonadherence to antihypertensive medications leads to uncontrolled high blood pressure and negative health outcomes, highlighting the need for improved strategies to enhance medication adherence.

Four key strategies are proposed to improve adherence: focusing on clinical outcomes, empowering patients, developing proactive care teams, and advocating for health care policy reform, which are essential for better management of hypertension.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

ASH position paper: Adherence and persistence with taking medication to control high blood pressure. Hill, MN., Miller, NH., DeGeest, S.[2021]

The pharmacist-physician collaborative practice model (PPCPM) significantly improved long-term blood pressure control rates in an underserved urban population, with 68% of patients achieving their blood pressure goals by 2013, compared to only 17% at baseline.

This model demonstrated effectiveness despite challenges such as high obesity rates and smoking prevalence, ranking in the 90th percentile of national quality benchmarks for hypertension management, highlighting the importance of interprofessional collaboration and accessible care.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Effectiveness of a Pharmacist-Physician Team-Based Collaboration to Improve Long-Term Blood Pressure Control at an Inner-City Safety-Net Clinic. Sisson, EM., Dixon, DL., Kildow, DC., et al.[2022]

A physician-nurse team model, utilizing home blood pressure monitoring, significantly improved long-term hypertension control, with the percentage of patients achieving target blood pressure levels rising from 0% to 63% over 12 months.

The study involved 106 patients, and results showed a notable decrease in mean blood pressure from 156/85 mm Hg at baseline to 131/75 mm Hg at 12 months, indicating effective management and adjustment of antihypertensive medications.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Improved blood pressure control with a physician-nurse team and home blood pressure measurement. Canzanello, VJ., Jensen, PL., Schwartz, LL., et al.[2013]

This study aims to improve blood pressure control and medication adherence among Latino adults with hypertension by implementing a tailored practice facilitation strategy in 10 safety-net primary care practices in New York.

The effectiveness of this strategy will be evaluated through a rigorous stepped-wedge cluster randomized controlled trial, focusing on both the fidelity of implementing the intervention and clinical outcomes like blood pressure control and medication adherence over 12 months.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Bridging the evidence-to-practice gap: a stepped-wedge cluster randomized controlled trial evaluating practice facilitation as a strategy to accelerate translation of a multi-level adherence intervention into safety net practices. Schoenthaler, A., De La Calle, F., Soto, A., et al.[2021]

In a 12-month study involving 463 patients with hypertension, those receiving collaborative management from primary care-pharmacist teams achieved significantly lower blood pressure levels compared to those receiving usual care, with systolic blood pressure at 137/75 mmHg versus 143/78 mmHg.

The intervention group also had a higher rate of achieving target blood pressure (<140/90 mmHg) at 62% compared to 44% in the control group, indicating that pharmacist involvement in hypertension management can enhance treatment effectiveness without negatively impacting quality of life or patient satisfaction.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

A randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertension. Hunt, JS., Siemienczuk, J., Pape, G., et al.[2022]

Citations

1.

pmc.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov/articles/PMC8572997/

Team-Based Care for Improving Hypertension Management

We evaluated the effect on long term blood pressure (BP) of an interprofessional team-based care (TBC) intervention, involving nurses, pharmacists, and ...

2.

cdc.gov

cdc.gov/high-blood-pressure/php/data-research/team-based-care/index.html

Team-Based Care to Improve Blood Pressure Control

Team-based care aims to enhance patient care by having health professionals from different disciplines work collaboratively with the patient and the patient's ...

3.

sciencedirect.com

sciencedirect.com/science/article/pii/S0033350624000398

Teamwork and its impact on chronic disease clinical ...

Studies with 4–5 team components were more effective in reducing systolic blood pressure and diastolic blood pressure. Heterogeneity should be considered ...

4.

researchgate.net

researchgate.net/publication/349282765_Assessment_of_Interprofessional_Collaborative_Practices_and_Outcomes_in_Adults_With_Diabetes_and_Hypertension_in_Primary_Care_A_Systematic_Review_and_Meta-analysis

Assessment of Interprofessional Collaborative Practices ...

Conclusions: For patients with Type 2 diabetes, team-based care improves blood glucose, blood pressure, and lipid levels. View. Show abstract.

5.

pmc.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov/articles/PMC7786771/

Patients' Experiences of Interprofessional Collaborative ...

Interprofessional collaboration (IPC) has been shown to improve patient safety and quality of care. Particularly, IPC assists health care providers to manage ...

6.

reporter.nih.gov

reporter.nih.gov/search/he6HLvjQDEeZFUkXTneuzA/project-details/11084360

RePORT ⟩ RePORTER

We're sorry but RePORTER doesn't work properly without JavaScript enabled. Please enable it to continue.